In line with our mission to improve quality of life of the patients and save lives, MSS team is supporting ICU staff using Therapeutic Plasma Exchange (TPE) and oXiris on Prismaflex machine from Baxter on COVID-19 positive patients in the Kingdom of Saudi Arabia. The oXiris set device obtained FDA Emergency Use Authorization (EUA) for the treatment of COVID-19 patients with severe symptoms. This device has the potential to clear patient blood from all substances not allowing the immune system to function normally. Our MSS way of confronting COVID-19! Stay safe! For more information, click below:

The most advanced 6k UHD laparoscopic tower VIMS, allowed experts in Dubai to follow a live broadcasted surgical procedure, performed by Prof. Chouillard at Poissy Saint-Germain-en-Laye Medical Center (France). From Dubai, Prof. Jamali and Prof. Al-Rassi moderated this interactive session, with direct cast and possible communication with Prof. Chouillard, in France.

For the 2nd year in a row, Med Surg Solutions was a Platinum Sponsor at the Pan Arab Interventional Radiology Society that was held in Dubai on February 26 to 29, 2020. The opportunity was present to meet the associates that are leading our efforts to transform medical unmet needs into solutions for better outcomes. MSS has organized many engaging and interactive sessions, to help doctors gain deeper insight into Gore device design, and TECcare Antimicrobial Technologies. They could also explore how our differentiated core technology and deep knowledge of material science contribute to creating products that help them achieve their goals for patient care.

With great pleasure, Med Surg Solutions took part in the Saudi National AAA screening project with his highness, the Director of King Abdulaziz University, Jeddah, Saudi Arabia. The University Health Promotion Screening program aimed to raise patient awareness on the importance of early diagnosis and treatment of Abdominal Aortic Aneurysm, especially since the majority of patients have no symptoms until rupture. Gore ® Excluder ® has proven performance and outcomes, in endovascular surgery, a less invasive procedure than an open repair. The screening campaign was launched in 2019, and will continue over 3 years. This project reflects MSS’s values of making a difference in the medical ecosystem and serving the wellbeing of patients.